Additionally, as the cell experiments showed that the LPL inhibitor Ibrolipim can inhibit the proliferation and migration of LUAD A549, PC-9, and H975 cells, in this part, we will further explore the potential regulatory and tumor-influencing mechanisms of LPL in LUAD. This evidence concerns the gene LPL and neoplasm.